ADAPTIMMUNE THERAPEUTICS PLC Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$34.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $556.00K.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$416.00K, a 170.75% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $588.00K.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-03-31 was -$1.27M.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$402.00K, a 145.84% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $877.00K.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$2.30M, a 729.86% decline from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was $365.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$34.00K 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | $556.00K 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | -$402.00K 10-K · filed 2025-03-24 | |||
| 2024-09-30 | -$222.00K 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | -$436.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | -$416.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $877.00K 10-K · filed 2025-03-24 | |||
| 2023-09-30 | $527.00K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | $398.00K 10-Q · filed 2024-08-12 | |||
| 2023-03-31 | $588.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$2.30M 10-K · filed 2025-03-24 | |||
| 2022-09-30 | -$6.79M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$5.84M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$1.27M 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $365.00K 10-K · filed 2024-03-06 | |||
| 2021-09-30 | -$1.18M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | -$937.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$204.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | -$960.00K 10-K · filed 2023-03-06 | |||
| 2020-09-30 | -$1.02M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$678.00K 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | -$502.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$372.00K 10-K · filed 2022-03-14 | |||
| 2019-09-30 | -$398.00K 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $289.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $425.00K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $3.33M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $4.11M 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $4.42M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $1.54M 10-Q · filed 2019-05-06 | |||
| 2017-09-30 | $2.22M 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | $2.43M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $1.49M 10-Q · filed 2018-05-09 |